Índice Bovespa

US Dollar vs BRL

Negocie de forma mais inteligente, não mais difícil: Libere seu potencial com nosso conjunto de ferramentas e discussões ao vivo.

Cadastre-se

Início
Investir
Ações
EUA
NASDAQ
Carmell Corporation (CTCX)
Carmell Corporation (CTCX) Notícias

CTCX

Carmell (CTCX)

Carmell Corporation

De:

Notícias regulamentadas

Procure um Texto:

Ordenação:

Notícias não regulamentadas

Apresentando as notícias mais relevantes sobre:NASDAQ:CTCX

1

Data	Hora	Fonte	Título	Código	Companhia
11/04/2024	17:30	GlobeNewswire Inc.	Carmell Announces Successful Closing of $3.0 Million Private Placement	NASDAQ:CTCX	Carmell Corporation
04/04/2024	09:30	GlobeNewswire Inc.	Carmell Announces $3.0 Million Private Placement	NASDAQ:CTCX	Carmell Corporation
27/03/2024	10:15	GlobeNewswire Inc.	Carmell Announces Successful Closing of Axolotl Biologix Sale Transaction	NASDAQ:CTCX	Carmell Corporation
20/03/2024	17:39	GlobeNewswire Inc.	Carmell Sharpens Aesthetics Focus with Execution of Definitive Agreement to Sell Axolotl Biologix Subsidiary	NASDAQ:CTCX	Carmell Corporation
18/03/2024	16:16	GlobeNewswire Inc.	Carmell to Host Investor Webinar, “Unveiling the Secretome: On the Eve of Product Launch” Featuring Key Opinion Leaders in the Medical Aesthetics Field	NASDAQ:CTCX	Carmell Corporation
26/02/2024	10:30	GlobeNewswire Inc.	Carmell Announces Product Development Completed for G.L.E.E. Launch in March 2024	NASDAQ:CTCX	Carmell Corporation
05/01/2024	18:39	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:CTCX	Carmell Corporation
19/12/2023	19:00	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:CTCX	Carmell Corporation
08/12/2023	18:46	Edgar (US Regulatory)	Form 3 - Initial statement of beneficial ownership of securities	NASDAQ:CTCX	Carmell Corporation
16/11/2023	10:30	GlobeNewswire Inc.	Carmell Corp Announces Addition of Scott Frisch and Gilles Spenlehauer to Board of Directors	NASDAQ:CTCX	Carmell Corporation
15/11/2023	18:56	Edgar (US Regulatory)	Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB	NASDAQ:CTCX	Carmell Corporation
25/10/2023	17:02	Edgar (US Regulatory)	Form 8-K/A - Current report: [Amend]	NASDAQ:CTCX	Carmell Corporation
12/09/2023	13:35	PR Newswire (US)	Moonshot Client Axolotl Announces Merger with Carmell Therapeutics, Elevating the Field of Regenerative Medicine	NASDAQ:CTCX	Carmell Corporation
05/09/2023	19:03	GlobeNewswire Inc.	Carmell Corporation Announces Completion of Post-Merger Integration with Axolotl Biologix and New Organizational Structure Aligned with Focus on Aesthetics	NASDAQ:CTCX	Carmell Corporation
14/08/2023	18:22	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:CTCX	Carmell Corporation
09/08/2023	16:41	Business Wire	Carmell Announces Successful Closing of Merger with Axolotl Biologix and Launch of a New Brand Identity	NASDAQ:CTCX	Carmell Corporation
07/08/2023	18:30	Edgar (US Regulatory)	Form S-1 - General form for registration of securities under the Securities Act of 1933	NASDAQ:CTCX	Carmell Corporation
27/07/2023	08:00	Business Wire	Carmell Therapeutics Announces Merger with Axolotl Biologix, a Profitable Regenerative Medicine Company	NASDAQ:CTCX	Carmell Corporation

Apresentando as notícias mais relevantes sobre:NASDAQ:CTCX

1

Natixis Structured Issua...

Societe Generale Effekten

Delayed Upgrade Clock

Suporte: (11) 4950 5808 | suporte@advfn.com.br

Ao acessar os serviços da ADVFN você estará de acordo com os Termos e Condições